Home Healthcare IT Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size, Share Report By 2028

Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028

Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size

According to Straits Research analysis, the Saudi Arabia Cell and Gene Therapy Manufacturing QC Market was valued at USD 25.13 Million in 2024 and is projected to reach USD 51.29 Million by 2028, expanding at a CAGR of 19.4% during the forecast period. This demand is primarily driven by applications in sectors like healthcare, agriculture and energy. In healthcare, advancements in regenerative medicine fuel the market growth while in agriculture, gene therapy is employed to enhance crop resistance. The burgeoning field of bioenergy explores this technology for optimal energy generation. Technological advancements and the capability to export these technologies present a significant opportunity for growth. As Saudi Arabia begins to position itself as a technology-driven economy, the cell and gene therapy manufacturing QC market is set to play a pivotal role in its transformation.

Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Highlights

  • In 2024, Cell Therapy accounted for the highest share of the Therapy Type market size.
  • During the forecast period, Gene Therapy is set to register the highest growth, making it the most lucrative Therapy Type segment.
  • Saudi Arabia accounted for 1.12% of the global cell and gene therapy manufacturing qc market size in 2024.
  • By 2028, United States is expected to remain the top global market in terms of size.
  • Within Middle East And Africa, Rest of MEA is forecasted to dominate the regional cell and gene therapy manufacturing qc market size by 2028.
  • South Africa will be the fastest-growing market in Middle East And Africa, projected to achieve USD 5913 Million by 2028.
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2028
Historical Period 2021-2023
Forecast Period 2025-2028
Market Size In 2024 USD 25.13 Million
Market Size In 2028 USD 51.29 Million
Largest segment Cell Therapy
Fastest segment Gene Therapy
Units Revenue in USD Million
CAGR 19.4% (2025-2028)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type

Segmentation Covered

Segments Sub Segments
Therapy Type
  1. Cell Therapy
  2. Gene Therapy
Cell Therapy
  1. CAR-T
  2. CAR-NK
  3. B-Cell
  4. Other
CAR-T
  1. Autologous CAR-T
  2. Allogeneic CAR-T
Gene Therapy
  1. Viral
  2. Non-Viral
Viral
  1. AAV
  2. Lentiviral vectors
  3. Other
Scale
  1. Pre commercial/ R&D Manufacturing
  2. Commercial Scale Manufacturing
Mode
  1. Contract Manufacturing
  2. In-house Manufacturing
Workflow
  1. Cell Processing
  2. Cell Banking
  3. Fill & Finish Operations
  4. Raw Material Testing
  5. Vector Production
  6. Other Workflows
Process
  1. Upstream Processes
  2. Downstream Processes
End User
  1. Pharmaceutical Companies
  2. Biopharmaceutical / Biotechnological Companies
  3. Contract Manufacturing Organizations
Pharmaceutical Companies
  1. Small Size
  2. Medium Size
  3. Large Size
Biopharmaceutical / Biotechnological Companies
  1. Small Size
  2. Medium Size
  3. Large Size
Contract Manufacturing Organizations
  1. Small Size
  2. Medium Size
  3. Large Size
Technology Type
  1. Fluorescence-Activated Cell Sorting (FACS)
  2. Enzyme-Linked Immunosorbent Assay (ELISA)
  3. Chromatography
  4. Next-Generation Sequencing (NGS)
  5. Polymerase Chain Reaction (PCR)
  6. Others 

Cell and Gene Therapy Manufacturing QC Market- Geographics


WhatsApp
Chat with us on WhatsApp